Empirical second-line therapy in 5000 patients of the European registry on Helicobacter pylori management (Hp-EuReg)
Background & Aims After a first Helicobacter pylori eradication attempt, approximately 20%
of patients will remain infected. The aim of the current study was to assess the effectiveness …
of patients will remain infected. The aim of the current study was to assess the effectiveness …
Effectiveness of first and second‐line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management
Abstract Background and Aims The optimal management of naïve and not naïve
Helicobacter pylori patients remains unclear. Therefore, it is essential to evaluate whether …
Helicobacter pylori patients remains unclear. Therefore, it is essential to evaluate whether …
European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 …
Objective The best approach for Helicobacter pylori management remains unclear. An audit
process is essential to ensure clinical practice is aligned with best standards of care. Design …
process is essential to ensure clinical practice is aligned with best standards of care. Design …
Bismuth quadruple regimen with tetracycline or doxycycline versus three‐in‐one single capsule as third‐line rescue therapy for Helicobacter pylori infection: Spanish data of the …
Background Different bismuth quadruple therapies containing proton‐pump inhibitors,
bismuth salts, metronidazole, and a tetracycline have been recommended as third‐line …
bismuth salts, metronidazole, and a tetracycline have been recommended as third‐line …
Helicobacter pylori second‐line rescue therapy with levofloxacin‐ and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth …
JP Gisbert, M Romano, AG Gravina… - Alimentary …, 2015 - Wiley Online Library
Background The most commonly used second‐line Helicobacter pylori eradication regimens
are bismuth‐containing quadruple therapy and levofloxacin‐containing triple therapy, both …
are bismuth‐containing quadruple therapy and levofloxacin‐containing triple therapy, both …
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis: CME
RJ Saad, P Schoenfeld, HM Kim… - Official journal of the …, 2006 - journals.lww.com
BACKGROUND Levofloxacin-based triple therapy has been suggested as an alternative
salvage therapy to bismuth-based quadruple therapy for persistent Helicobacter pylori (H …
salvage therapy to bismuth-based quadruple therapy for persistent Helicobacter pylori (H …
Comparison of 10‐day levofloxacin bismuth‐based quadruple therapy and levofloxacin‐based triple therapy for Helicobacter pylori
TS Wu, PI Hsu, CH Kuo, HM Hu, IC Wu… - Journal of digestive …, 2017 - Wiley Online Library
OBJECTIVE This was a prospective study aiming to investigate whether levofloxacin plus
bismuth‐based quadruple therapy was more effective than levofloxacin‐based triple therapy …
bismuth‐based quadruple therapy was more effective than levofloxacin‐based triple therapy …
Fourteen-day optimized levofloxacin-based therapy versus classical quadruple therapy for Helicobacter pylori treatment failures: a randomized clinical trial
Z Cao, Q Chen, W Zhang, X Liang, J Liao… - Scandinavian journal …, 2015 - Taylor & Francis
Objective. To test the efficacy of lansoprazole, bismuth, levofloxacin, and amoxicillin therapy
compared to bismuth metronidazole tetracycline (BMT) quadruple therapy for second-line …
compared to bismuth metronidazole tetracycline (BMT) quadruple therapy for second-line …
Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple “sequential” or “concomitant” treatment to eradicate H. pylori infection
JP Gisbert, J Molina-Infante, AC Marin… - Scandinavian journal …, 2013 - Taylor & Francis
Background. Non-bismuth quadruple “sequential” and “concomitant” regimens, including a
proton pump inhibitor (PPI), amoxicillin, clarithromycin and a nitroimidazole, are increasingly …
proton pump inhibitor (PPI), amoxicillin, clarithromycin and a nitroimidazole, are increasingly …
[HTML][HTML] First-line therapies for Helicobacter pylori eradication: a critical reappraisal of updated guidelines
V De Francesco, A Bellesia, L Ridola… - Annals of …, 2017 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) treatment remains a challenge for the clinician, as no available
therapy is able to cure the infection in all treated patients. In the last two decades, several …
therapy is able to cure the infection in all treated patients. In the last two decades, several …